Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, Jan. 24 '26)

Image
By G.M.

 


    Ann Intern Med

  1. SACKS HS
    In older adults, RSV prefusion F vaccine reduced hospitalization for RSV-related respiratory tract disease vs. no vaccine.
    Ann Intern Med. 2026 Jan 6. doi: 10.7326/ANNALS-25-05113.
    PubMed         Abstract available

  2. SOUMARE A, Kapfer T, Botrel T, Adda L, et al
    Systemic Corticosteroids, Mortality, and Infections in Pneumonia and Acute Respiratory Distress Syndrome : A Systematic Review and Meta-analysis.
    Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-03055.
    PubMed         Abstract available


    Arch Virol

  3. LAI QR, Chen W, Yu GF, Guo YJ, et al
    Molecular epidemiology and clinical characteristics of human adenovirus in children in Hangzhou (2022-2023).
    Arch Virol. 2026;171:60.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  4. WU X, Bhatt V, Liu JJ, Hong L, et al
    Single-cell RNA sequencing data analysis reveals differential expressions of ion channels in immunity response to pulmonary COVID-19 infection.
    Biochem Biophys Res Commun. 2026;800:153273.
    PubMed         Abstract available


    BMC Pediatr

  5. AYKAC K, Demir OO, Sari MC, Kuruc AI, et al
    Hepatitis is an underestimated complication among children with pneumonia associated with SARS-CoV-2 and influenza: a single center study.
    BMC Pediatr. 2026 Jan 21. doi: 10.1186/s12887-025-06481.
    PubMed        


    BMJ

  6. RUSSELL MD, Schaffer A, Bechman K, Gibson M, et al
    Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELY.
    BMJ. 2026;392:e086393.
    PubMed         Abstract available


    Epidemiol Infect

  7. WANG B, Zhang T, Yi L, Wu Y, et al
    Incidence of community-acquired pneumonia among adults between 2016 and 2023: an observational cohort study.
    Epidemiol Infect. 2026;154:e15.
    PubMed         Abstract available

  8. DHAWAN S, Pan-Ngum W, MacIntyre CR, Blacksell SD, et al
    Epidemiological indicators of accidental laboratory-origin outbreaks.
    Epidemiol Infect. 2026;154:e16.
    PubMed         Abstract available


    J Infect Dis

  9. ZHANG X
    How "Enhanced" Are Enhanced Influenza Vaccines for Neuraminidase? Antigen Content and Baseline Immunity Revisited.
    J Infect Dis. 2026 Jan 23:jiag042. doi: 10.1093.
    PubMed        

  10. ORLINICK B, Mehta S, McAlpine L, Khoshbakht S, et al
    Cerebrospinal Fluid Immune Cell Alterations in Women With Neuropsychiatric Long COVID.
    J Infect Dis. 2026;233:e109-e117.
    PubMed         Abstract available

  11. SONG EM, An HM, Kim SE, Shim KN, et al
    Coronavirus Disease 2019 Risk in Patients With Autoimmune Diseases Using Biologics or Small Molecules: A Population-Based Cohort Study.
    J Infect Dis. 2026;233:137-147.
    PubMed         Abstract available

  12. BIDARI S, Yuan H, Yang W
    Assessing the Transmissibility and Outbreak Risk of Measles in the United States, 2024-2030.
    J Infect Dis. 2026;233:132-136.
    PubMed         Abstract available


    J Virol

  13. YANG Q, Xue B, Qiu X, Yang K, et al
    Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC.
    J Virol. 2026;100:e0148725.
    PubMed         Abstract available

  14. HAWKINS GM, Qing E, Salgado J, Chan P, et al
    A murine coronavirus infection platform identifies proviral and proinflammatory activities of SARS-CoV-2 accessory protein 7a.
    J Virol. 2025 Dec 16:e0196124. doi: 10.1128/jvi.01961.
    PubMed         Abstract available

  15. FONSECA BF, Robinot R, Michel V, Mendez A, et al
    Stealth replication of SARS-CoV-2 Omicron in the nasal epithelium at physiological temperature.
    J Virol. 2025 Dec 19:e0200825. doi: 10.1128/jvi.02008.
    PubMed         Abstract available

  16. BRIGLEB PH, Sharp B, Lazure L, Livingston B, et al
    Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses.
    J Virol. 2026 Jan 22:e0208825. doi: 10.1128/jvi.02088.
    PubMed         Abstract available


    Pediatrics

  17. BYINGTON CL, Stellwagen L, Bode L, Hooshmand M, et al
    Milk as a Transmission Vehicle for Highly Pathogenic Avian Influenza A (H5N1).
    Pediatrics. 2026 Jan 22:e2025072525. doi: 10.1542/peds.2025-072525.
    PubMed         Abstract available


    PLoS Comput Biol

  18. PELLOW R, Comeron JM
    A wavelet-based approach generates quantitative, scale-free and hierarchical descriptions of 3D genome structures and new biological insights.
    PLoS Comput Biol. 2026;22:e1013887.
    PubMed         Abstract available

  19. ADEGBAJU MS, Owo-Odusi O, Wirtz ET, Morenikeji OB, et al
    Structural analysis of antigenic variation and adaptive evolution of the H5N1 neuraminidase gene.
    PLoS Comput Biol. 2026;22:e1013903.
    PubMed         Abstract available


    PLoS Med

  20. TATEMATSU D, Nakamura N, Abe MS, Ishikawa T, et al
    Psychological distress among Japanese high school students during the COVID-19 pandemic: An energy landscape analysis.
    PLoS Med. 2026;23:e1004884.
    PubMed         Abstract available

  21. MONOI A, Endo A, Procter SR, Leuba SI, et al
    The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study.
    PLoS Med. 2026;23:e1004625.
    PubMed         Abstract available


    PLoS One

  22. ROHNER S, Schnepper R, Meienberg A, Bopp K, et al
    Protocol of the digital long COVID study: A single-center, registry-based, feasibility and clinical evaluation study to investigate a 12-week digital intervention program for people affected by post-COVID-19 condition.
    PLoS One. 2026;21:e0340385.
    PubMed         Abstract available

  23. PARK J, Koo JH, Kang S
    Urban density and depression during COVID-19 in Seoul: Moderating effects of social participation.
    PLoS One. 2026;21:e0339040.
    PubMed         Abstract available

  24. PATEL N, Sharma R, Lingasamy P, Sundararajan V, et al
    Temporal evolution of digital health communication in Rheumatoid Arthritis: A longitudinal NLP analysis of reddit discussions (2018-2024).
    PLoS One. 2026;21:e0341006.
    PubMed         Abstract available

  25. JOSHI DR, Khanal J, Joshi BM
    Investigating the relationship between teacher efficacy, job satisfaction, and digital resource utilization in assessment practices: Insights from PISA 2018 and 2022.
    PLoS One. 2026;21:e0339475.
    PubMed         Abstract available

  26. ADENIJI OA, Pappas E, Stenner K, Traynor V, et al
    Weathering the storm of COVID-19 pandemic: A cross-sectional survey of reported changes in first contact physiotherapy services in the UK and Australia.
    PLoS One. 2026;21:e0340995.
    PubMed         Abstract available

  27. OKUI T
    Age-specific impact of COVID-19 on birth rates in Japan: An interrupted time-series analysis using national vital statistics.
    PLoS One. 2026;21:e0341340.
    PubMed         Abstract available

  28. LYU Z, Murtaza N
    Impact of crowdfunding, entrepreneurial finance and varieties of entrepreneurial ecosystems after COVID pandemic for rural women.
    PLoS One. 2026;21:e0340966.
    PubMed         Abstract available

  29. MIYAMORI D, Yoshida S, Omori W, Kashima S, et al
    Impact of COVID-19 on new pharmacotherapy for insomnia: A matched cohort study using the national insurance claims database in Japan.
    PLoS One. 2026;21:e0341416.
    PubMed         Abstract available

  30. AGASI-IDENBURG C, de Kruif A, Ronteltap A, van Oers S, et al
    Allied health care in the early stages of the COVID-19 pandemic: A qualitative study on the perceptions of non-hospitalized patients and allied health professionals.
    PLoS One. 2026;21:e0341308.
    PubMed         Abstract available

  31. NOVAK P, Systrom DM, Witte A, Marciano SP, et al
    Shared autonomic phenotype of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome.
    PLoS One. 2026;21:e0341278.
    PubMed         Abstract available

  32. BELALCAZAR AT, Lasso VM, Alvarez Herazo JD, Clarete A, et al
    Rethinking emergency risk assessment: A single-center look at shock index and its variants in COVID-19.
    PLoS One. 2026;21:e0341634.
    PubMed         Abstract available

  33. MACK M, Ye A, Ursu S, Ice R, et al
    HEDGES co-prevents both SARS-CoV-2 and pandemic influenza infection in mice by rapid, durable co-production of twelve different anti-pandemic monoclonal antibodies.
    PLoS One. 2026;21:e0309923.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  34. SRINIVASAN S, King J, Collins JM, Colubri A, et al
    Real-time spatiotemporal tracking of infectious outbreaks in confined environments with a host-pathogen agent-based system.
    Proc Natl Acad Sci U S A. 2026;123:e2422574123.
    PubMed         Abstract available

  35. TE N, Chin AWH, Gu H, Zhirong Jia J, et al
    Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage.
    Proc Natl Acad Sci U S A. 2026;123:e2518645123.
    PubMed         Abstract available


    Vaccine

  36. JEONG O, Choi W, Ahn H, Lee S, et al
    Bromelain-cleaved hemagglutinin production from cell culture-derived influenza viruses enhances vaccine potency quantification by single radial immunodiffusion assay.
    Vaccine. 2026;75:128235.
    PubMed         Abstract available

  37. LISTER H, Farquharson K, Seale H, Smith LE, et al
    Erratum to "A systematic review of the impact of vaccine reactogenicity on willingness to accept influenza vaccination in adults" [Vaccine 74 (2026) 128195].
    Vaccine. 2026;75:128252.
    PubMed        

  38. CONTARINO F, Fiorilla C, Bella F, Orsi A, et al
    Exploring regional variations in the provision of influenza vaccination in Italy.
    Vaccine. 2026;75:128266.
    PubMed         Abstract available


    Virology

  39. NGUYEN CT, Nakayama M, Yasui F, Ishigaki H, et al
    Vaccinia virus-based SARS-CoV-2 vaccine prevents lung immunopathology without antibody-dependent enhancement in female rhesus macaques.
    Virology. 2025;616:110778.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »